Evidence map›Paper›PMID 39994592›Full record

ArticleBMC pregnancy and childbirth2025

Commentary: Antenatal corticosteroid prophylaxis in late preterms- short- and long-term effects and many open questions.

Viktoria Jost, Herbert Fluhr, Hanns Helmer, Christian Göbl

Abstract readLetterComment
In one paragraph

Article in BMC pregnancy and childbirth, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Viktoria JostDepartment of Obstetrics and Gynaecology, Division of Obstetrics, Medical University of Graz, Graz, Austria.
Herbert FluhrDepartment of Obstetrics and Gynaecology, Division of Obstetrics, Medical University of Graz, Graz, Austria.
Hanns HelmerDepartment of Obstetrics and Gynaecology, Division of Obstetrics and feto-maternal Medicine, Medical University of Vienna, Währinger Gürtel 18-20, Vienna, A-1090, Austria.
Christian GöblDepartment of Obstetrics and Gynaecology, Division of Obstetrics, Medical University of Graz, Graz, Austria. Christian.goebl@meduniwien.ac.at.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antenatal corticosteroids are a well-established treatment for fetal lung maturation before 34 + 0 weeks of gestation. The administration of dexamethasone and betamethasone in late preterm - between 34 + 0 and 36 + 6 weeks of gestation - is still highly debated and subject of recent research. This topic was recently addressed by a retrospective observational cohort study aiming to investigate the benefits, short- and long-term risks of the application of antenatal corticosteroids in the late preterm phase. This commentary will discuss the main findings of the article and its implications for further research.

Indexed as

Adrenal Cortex HormonesBetamethasoneDexamethasoneGlucocorticoidsPremature BirthPrenatal CareRespiratory Distress Syndrome, NewbornFemaleFetal Organ MaturityGestational AgeHumansInfant, NewbornInfant, PrematurePregnancyRetrospective StudiesAdrenal Cortex HormonesBetamethasoneDexamethasoneGlucocorticoids

Identifiers

PMID39994592
PMCPMC11849386

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.